ArticleDrug safety2025

Evaluation of Mortality in Users of Pimavanserin Compared with Other Atypical Antipsychotics in Patients with Parkinson's Disease Psychosis: An Update.

Sapna Rao et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.